Skip to main content
Livermore
Livermore
ZHEN

S&T Bank

SEC CIK
0001010911
Latest filing
Aug 12, 2026

CORT holding history

Corcept Therapeutics Inc in every 13F filed by S&T Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CORT overviewAll 13F holders of CORTFull Q2 2026 holdings

Shares (Q2 2026)
55,553
Value
$4.83M
% of portfolio
1.4%
Quarters held
22
Since Q1 2021
Holdings of CORT by S&T Bank, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202655,553$4.83M1.4%−12,534−18.4%ReducedHolders
Q1 202668,087$2.74M1.0%−25,185−27.0%ReducedHolders
Q4 202593,272$3.25M1.0%−18,068−16.2%ReducedHolders
Q3 2025111,340$9.25M2.6%−13,768−11.0%ReducedHolders
Q2 2025125,108$9.18M2.8%−19,187−13.3%ReducedHolders
Q1 2025144,295$16.5M5.4%−12,390−7.9%ReducedHolders
Q4 2024156,685$7.90M2.5%−29,331−15.8%ReducedHolders
Q3 2024186,016$8.61M2.3%−13,775−6.9%ReducedHolders
Q2 2024199,791$6.49M1.7%−90,696−31.2%ReducedHolders
Q1 2024290,487$7.32M1.4%−30,349−9.5%ReducedHolders
Q4 2023320,836$10.4M1.9%−13,416−4.0%ReducedHolders
Q3 2023334,252$9.11M1.8%−13,008−3.7%ReducedHolders
Q2 2023347,260$7.73M1.4%−3,664−1.0%ReducedHolders
Q1 2023350,924$7.60M1.4%+4,618+1.3%AddedHolders
Q4 2022346,306$7.03M1.3%−3,150−0.9%ReducedHolders
Q3 2022349,456$8.96M1.7%−149,083−29.9%ReducedHolders
Q2 2022498,539$11.9M2.1%−10,007−2.0%ReducedHolders
Q1 2022508,546$11.5M1.7%−5,281−1.0%ReducedHolders
Q4 2021513,827$10.2M1.5%+28,451+5.9%AddedHolders
Q3 2021485,376$9.55M1.5%−8,038−1.6%ReducedHolders
Q2 2021493,414$10.9M1.7%−4,111−0.8%ReducedHolders
Q1 2021497,525$11.8M2.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.